Financials and Filings

MGEN $0.59 $ + 0.01 (1.24%)

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
10-Q 10-Q 11/8/2019 9/30/2019
8-K 8-K 11/7/2019 11/7/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 10/31/2019 10/31/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.
8-K 8-K 10/16/2019 10/16/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-Q 10-Q 8/8/2019 6/30/2019
8-K 8-K 8/7/2019 8/7/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Termination of a Material Definitive Agreement; Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; and Financial Statements and Exhibits.
8-K 8-K 7/19/2019 7/19/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 6/21/2019 6/20/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Submission of Matters to a Vote of Security Holder.
8-K 8-K 5/21/2019 5/21/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-Q 10-Q 5/9/2019 3/31/2019
8-K 8-K 5/8/2019 5/8/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
Proxy DEF 14A 5/3/2019 6/19/2019
Proxy DEFA14A 5/3/2019
8-K 8-K 4/29/2019 4/29/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 4/26/2019 4/26/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-K 10-K 3/14/2019 12/31/2018
Registration Statement S-8 3/14/2019
8-K 8-K 3/13/2019 3/13/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 2/8/2019 2/8/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 1/24/2019 1/24/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement.

Displaying 1 to 20 (of 208 filings)